Announced Thu, 1 Oct, 2026 · 14:35 IST
US FDA closes Jeevan Scientific inspection with Zero 483 observations
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹85.00
prior close
₹82.81
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+1.4+1.4+1.5-1.8+1.8+2.4-2.7——————
Up moveDown movePending
AI summary
US FDA concluded inspection of Jeevan Scientific's bioanalytical facility in Hyderabad on 30 Sep 2026. The July 2026 inspection closed with Zero 483 observations, meaning no adverse findings. The Establishment Inspection Report (EIR) has been released, marking a clean regulatory outcome for the company.
Likely market impact
Positive for shareholders - clean US FDA outcome strengthens compliance standing and business credibility with no adverse observations reported.